美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BillionToOne, Inc.

120.25

+60.25100.41%

成交量：107.75万

成交额：1.15亿

市值：52.93亿

市盈率：- -

高：123.84

开：100.00

低：95.00

收：60.00

52周最高：123.84

52周最低：95.00

股本：4,401.53万

流通股本：384.60万

量比：- -

换手率：28.02%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：-21.15

市盈率(LYR):- -

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

异动解读 | BillionToOne盘中大涨66.67%，IPO首日开盘价超预期

异动解读 | BillionToOne上市首日，股价盘中大涨66.67%

BUZZ-BillionToOne 首次登陆纳斯达克，开盘价将比发行价高出 33

重发-更新 1-分子诊断公司 BillionToOne 在美国首次公开募股中融资 2.73 亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BLLN"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLLN\",,,,,undefined,":{"symbol":"BLLN","market":"US","secType":"STK","nameCN":"BillionToOne, Inc.","latestPrice":120.245,"timestamp":1762459082132,"preClose":60,"halted":0,"volume":1077472,"delay":0,"floatShares":3846000,"shares":44015300,"eps":0,"marketStatus":"交易中","change":60.245,"latestTime":"11-06 14:58:05 EST","open":100,"high":123.84,"low":95,"amount":114512431.1936,"amplitude":0.480667,"askPrice":120.49,"askSize":202,"bidPrice":119.1,"bidSize":20,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1762462800000},"marketStatusCode":2,"adr":0,"listingDate":1762405200000,"exchange":"NASDAQ","adjPreClose":60,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLLN\",,,,,undefined,":{"symbol":"BLLN","floatShares":3846000,"roa":"--","roe":"--","lyrEps":0,"shares":44015300,"dividePrice":0,"high":123.84,"amplitude":0.480667,"preClose":60,"low":95,"week52Low":95,"pbRate":"-21.15","psRate":"25.32","week52High":123.84,"institutionHeld":0,"latestPrice":120.245,"committee":-0.81982,"eps":0,"divideRate":0,"volume":1077472,"delay":0,"ttmEps":0,"open":100,"prevYearClose":60,"prevWeekClose":60,"prevMonthClose":60,"prevQuarterClose":60,"fiveDayClose":60,"twentyDayClose":60,"sixtyDayClose":60},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLLN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLLN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLLN\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191654904","title":"异动解读 | BillionToOne盘中大涨66.67%，IPO首日开盘价超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1191654904","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191654904?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 01:42","pubTimestamp":1762450934,"startTime":"0","endTime":"0","summary":"分子诊断公司BillionToOne, Inc.今日在纳斯达克首次公开交易，盘中大涨66.67%，引起市场广泛关注。据悉，BillionToOne的股票开盘价为每股100美元，较60美元的发行价大幅上涨66.7%。值得注意的是，BillionToOne最初计划发行385万股，每股价格区间为49美元至55美元，但最终定价高于预期区间。总部位于加利福尼亚州门洛帕克市的BillionToOne主要开发分子诊断测试，包括针对各种疾病的无创产前筛查和液体活检。BillionToOne的强劲debut表明投资者对其业务前景及生物科技行业整体保持乐观态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"1131573131","title":"异动解读 | BillionToOne上市首日，股价盘中大涨66.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131573131","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131573131?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 01:42","pubTimestamp":1762450934,"startTime":"0","endTime":"0","summary":"分子诊断公司BillionToOne今日在纳斯达克证券交易所首次亮相，股价表现亮眼，盘中大涨66.67%，引发市场广泛关注。据悉，BillionToOne的IPO发行价为每股60美元，而开盘价高达100美元，较发行价溢价66.7%。值得注意的是，BillionToOne最初计划发行385万股，每股价格区间为49美元至55美元，但最终定价明显高于预期区间。此次成功上市不仅为BillionToOne带来了可观的融资，也反映了投资者对其业务前景的看好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"2581097986","title":"BUZZ-BillionToOne 首次登陆纳斯达克，开盘价将比发行价高出 33","url":"https://stock-news.laohu8.com/highlight/detail?id=2581097986","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581097986?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 23:33","pubTimestamp":1762443192,"startTime":"0","endTime":"0","summary":"11月6日 - ** 分子诊断公司BillionToOne的BLLN.O股票在纳斯达克首次上市时的开盘价将比发行价高出33.3%。** BLLN 开发分子诊断测试，包括针对各种疾病的无创产前筛查和液体活检。** 在截至 6 月 30 日的六个月中，BLLN 的收入激增 82%，达到 1.255 亿美元，净亏损缩小至 420 万美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4S3WI1TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","BLLN","PIPR"],"gpt_icon":0},{"id":"2581036418","title":"重发-更新 1-分子诊断公司 BillionToOne 在美国首次公开募股中融资 2.73 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581036418","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581036418?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 12:09","pubTimestamp":1762402178,"startTime":"0","endTime":"0","summary":"更新版 1-重发-更新 1-分子诊断公司 BillionToOne 在美国首次公开募股中融资 2.73 亿美元在第6段和第8-10段增加了细节和背景介绍。路透11月6日 - 分子诊断公司BillionToOne BLLN.O周三在美国首次公开募股中募集了2.731亿美元，股票定价高于市场范围。BillionToOne 是一家分子诊断公司，利用其单分子测序技术开发无创产前检查和肿瘤血液检查。BillionToOne 将在纳斯达克上市，股票代码为 \"BLLN\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4T3WI0CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIPR","BK4127","BLLN"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BLLN\",params:#limit:6,delay:false,,,undefined,":[]}}